Tolvaptan Tablet
Product Images NDC 72205-131

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tolvaptan (NDC 72205-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tolvaptan-15mg-blstr-crtn (Tolvaptan 15mg Blstr Crtn)

Tolvaptan Tablets 15 mg oral tablets packaging label by Novadoz Pharmaceuticals LLC. The carton contains 10 tablets (1 strip with 10 unit-dose tablets). The label specifies hospital initiation, pharmacist instructions to provide Medication Guide, storage conditions, and manufacturer details (MSN Laboratories Private Limited, India). NDC 72205-130-11 is shown with barcodes and contact information.*

FDA Label Image

Tolvaptan-15mg-blstr-foil (Tolvaptan 15mg Blstr Foil)

This image shows labels for Tolvaptan Tablet 15 mg distributed by Novadoz Pharmaceuticals LLC. Each label includes the Rx only designation, NDC 72205-130-11, barcode, and placeholders for lot number and expiration date. The labels indicate the product is made in India and were issued in 03/2023. Directions for use include peel and push instructions for tablet retrieval.*

FDA Label Image

Tolvaptan-30mg-blstr-crtn (Tolvaptan 30mg Blstr Crtn)

Tolvaptan Tablets 30 mg oral tablets packaging label showing a carton containing 10 tablets in a single strip of unit-dose tablets. The label includes instructions to dispense the medication guide to each patient and storage information. The product is labeled as Rx only and manufactured by MSN Laboratories Private Limited, distributed by Novadoz Pharmaceuticals LLC.*

FDA Label Image

Tolvaptan-30mg-blstr-foil (Tolvaptan 30mg Blstr Foil)

Packaging label for Tolvaptan Tablet 30 mg distributed by Novadoz Pharmaceuticals LLC. The label features multiple identical tablet blister segments, each marked with 'Rx only', NDC 72205-131-11, lot and expiration placeholders, and a barcode. Manufactured in India, issued date 03/2023. Instructions for 'Peel & Push' to access tablets are indicated.*

FDA Label Image

Tolvaptan-figure-1 (Tolvaptan Figure 1)

A line graph comparing mean serum sodium levels (mEq/L) over a 30-day treatment period plus a 7-day follow-up between TOLVAPTAN (15-60 mg) and placebo groups. The graph shows data points with standard deviation error bars, highlighting statistically significant differences favoring TOLVAPTAN starting around day 2 through day 30.*

FDA Label Image

Tolvaptan-figure-2 (Tolvaptan Figure 2)

A line graph comparing mean serum sodium levels over treatment days in patients receiving Tolvaptan 15-60 mg versus placebo. The x-axis shows treatment days from baseline to day 30 and a 7-day follow-up, while the y-axis shows mean serum sodium in mEq/L. Tolvaptan shows an increase in serum sodium compared to placebo throughout the period, with error bars indicating standard deviation.*

FDA Label Image

Tolvaptan-figure-3 (Tolvaptan Figure 3)

A line graph depicting mean serum sodium levels (mEq/L) over time in weeks for patients treated with Tolvaptan 15-60 mg (N=111). The x-axis shows time points from baseline through 50 weeks, including specific days and weeks. Mean serum sodium values increase from baseline with standard deviation bars and statistically significant differences indicated at multiple time points.*

FDA Label Image

Tolvaptan-structure (Tolvaptan Structure)

Chemical structure diagram of the active ingredient Tolvaptan, showing its molecular arrangement including functional groups and ring systems.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.